Sanford Bernstein analyst Pierre Ferragu questions about organic growth in 3Q16 & 4Q16. $MSI says that outlook is supported by the fact that product backlog is up sequentially & annually. The company expects Products revenue to improve in 3Q16 & return to growth in 4Q16. As Latin America is stabilizing, $MSI expects organic growth to return in 2H16

Read a media report stating that good times are coming to an end for Dollar stores. If you ask me, there appears to be no cloud on the horizon and major Dollar stores like $DG and $DLTR are doing well for sure.

$LLY and $AZN announced a worldwide agreement to co-develop MEDI1814 for potential disease-modifying treatment for Alzheimer's disease (AD). Under terms, $LLY will make a $30MM upfront payment to $AZN. $LLY will recognize upfront $30MM pretax or about $0.02 per share after-tax, as a charge to earnings in 4Q16.

$SCVL said its BoD authorized a new share repurchase program for
up to $50MM of its outstanding common stock, effective January 1, 2017. The new
share repurchase program will replace the existing $50MM share repurchase
program that was authorized on December 9, 2015, which will expire in
accordance with its terms on December 31, 2016.

$LLY and $AZN announced a worldwide agreement to co-develop MEDI1814, an antibody selective for amyloid-beta 42, which is currently in Phase 1 trials as potential disease-modifying treatment for Alzheimer's disease (AD). This agreement builds on existing collaboration related to AZD3293, BACE inhibitor in two pivotal Phase 3 trials.

$JJSF said its BoD has declared a regular quarterly cash dividend
of $0.42 per share of its common stock payable on January 11, 2017 to
shareholders of record as of December 21, 2016. The cash dividend of $0.42 per
share represents an increase of 7.7% from the previous quarterly dividend rate
of $0.39 per share.